Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Darcy

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
International Journal of Pharmaceutics|September 17, 2017
Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumoursJames C Evans, Meenakshi Malhotra, Katrina Sweeney, et al.
Pharmaceutical Research|November 30, 2012
In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA deliveryAoife M O'Mahony, Stephane Desgranges, Julien Ogier, et al.
Molecular Pharmaceutics|February 2, 2017
Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic EfficacyJianfeng Guo, Eileen G Russell, Raphael Darcy, et al.
Molecular Pharmaceutics|February 6, 2019
Self-Assembled Cationic β-Cyclodextrin Nanostructures for siRNA DeliveryRaghvendra Pratap Singh, Tania Hidalgo, Pierre-Andre Cazade, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 16, 2003
Novel heterotopic colloids of anionic porphyrins entangled in cationic amphiphilic cyclodextrins: spectroscopic investigation and intracellular deliveryAntonino Mazzaglia, Nicola Angelini, Raphael Darcy, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 24, 2015
Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysisMatt Gooding, Meenakshi Malhotra, David J McCarthy, et al.
International Journal of Pharmaceutics|July 4, 2014
PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stabilityBruno M D C Godinho, Julien R Ogier, Aoife Quinlan, et al.
Biomaterials|July 22, 2015
The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeuticsKathleen A Fitzgerald, Jianfeng Guo, Erica G Tierney, et al.
Molecular Pharmaceutics|January 4, 2017
Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases ModelJames C Evans, Meenakshi Malhotra, Kathleen A Fitzgerald, et al.
International Journal of Pharmaceutics|August 6, 2016
Nanoparticle-mediated siRNA delivery assessed in a 3D co-culture model simulating prostate cancer bone metastasisKathleen A Fitzgerald, Jianfeng Guo, Rosanne M Raftery, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Pharmaceutics|September 17, 2017
Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumoursJames C Evans, Meenakshi Malhotra, Katrina Sweeney, et al.
Pharmaceutical Research|November 30, 2012
In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA deliveryAoife M O'Mahony, Stephane Desgranges, Julien Ogier, et al.
Molecular Pharmaceutics|February 2, 2017
Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic EfficacyJianfeng Guo, Eileen G Russell, Raphael Darcy, et al.
Molecular Pharmaceutics|February 6, 2019
Self-Assembled Cationic β-Cyclodextrin Nanostructures for siRNA DeliveryRaghvendra Pratap Singh, Tania Hidalgo, Pierre-Andre Cazade, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 16, 2003
Novel heterotopic colloids of anionic porphyrins entangled in cationic amphiphilic cyclodextrins: spectroscopic investigation and intracellular deliveryAntonino Mazzaglia, Nicola Angelini, Raphael Darcy, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 24, 2015
Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysisMatt Gooding, Meenakshi Malhotra, David J McCarthy, et al.
International Journal of Pharmaceutics|July 4, 2014
PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stabilityBruno M D C Godinho, Julien R Ogier, Aoife Quinlan, et al.
Biomaterials|July 22, 2015
The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeuticsKathleen A Fitzgerald, Jianfeng Guo, Erica G Tierney, et al.
Molecular Pharmaceutics|January 4, 2017
Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases ModelJames C Evans, Meenakshi Malhotra, Kathleen A Fitzgerald, et al.
International Journal of Pharmaceutics|August 6, 2016
Nanoparticle-mediated siRNA delivery assessed in a 3D co-culture model simulating prostate cancer bone metastasisKathleen A Fitzgerald, Jianfeng Guo, Rosanne M Raftery, et al.
Pageof 4